Trends of utilization and outcomes after transcatheter and surgical aortic valve replacement on chronic dialysis

Tomo Ando1, Alexandros Briasoulis2, Hisato Takagi3

  • 1Division of Cardiology, Center for Interventional Vascular Therapy, New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA.

Journal of Cardiac Surgery
|September 28, 2020
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) utilization increased significantly in patients on chronic dialysis (CD), surpassing surgical aortic valve replacement (SAVR). However, outcomes require improvement for this high-risk group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nephrology

Background:

  • Transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are crucial for aortic valve stenosis.
  • Patients on chronic dialysis (CD) represent a high-risk population for these procedures.
  • Limited data exists on the utilization and outcomes of TAVR versus SAVR in CD patients.

Purpose of the Study:

  • To evaluate the trends in utilization of TAVR and SAVR.
  • To compare the in-hospital outcomes of TAVR and SAVR in patients with CD.
  • To identify potential areas for improving aortic valve replacement outcomes in CD patients.

Main Methods:

  • Analysis of the Nationwide Readmission Databases from 2013 to 2017.
  • Identification of TAVR and SAVR procedures using ICD-CM codes.
  • Multivariable regression analysis to compare outcomes, including adjusted odds ratios (aOR) and 95% confidence intervals (CI).

Main Results:

  • TAVR utilization increased four-fold, while SAVR increased 33% among CD patients.
  • TAVR volume surpassed SAVR in CD patients by 2016-2017.
  • In-hospital mortality remained similar for TAVR but increased for SAVR; however, 2017 data showed higher mortality and readmission for TAVR in CD versus non-CD patients.

Conclusions:

  • TAVR use has significantly increased in patients on chronic dialysis.
  • Despite increased utilization, outcomes for TAVR in CD patients warrant further investigation and improvement.
  • There is a continued need to optimize aortic valve replacement strategies for the CD population.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
824
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
377
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
212
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
465
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
273
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
509